Eptifibatide Injection

Category:Finished Dosage > Blood System drug Preparations
Product Name:Eptifibatide Injection
CAS No.:--
Standard:ChP, In-house Standards, Ph. Int
Company:Hainan Shuangcheng Pharmaceuticals Co.,Ltd.

Basic Info
  • Grade: Injection Grade

    Factory Location: Haikou, Hainan

    Main Sales Markets: North America,Eastern Europe,Asia,Middle East

  • Monthly Production Capacity: 80,000 vials

    Packaging Information: --

  • Delivery Lead Time: 2 months

    Sample Provided: no

    Payment Terms: T/T

    EPTIFIBATIDE injection, for intravenous use
    ANDA review/NMPA review


    Note: the content below does not include all the information needed to use Eptifibatide injection safely and effectively. 



    Eptifibatide injection is a platelet aggregation inhibitor indicated for:

    • Treatment of acute coronary syndrome (ACS) managed medically or with percutaneous coronary intervention (PCI).

    • Treatment of patients undergoing PCI (including intracoronary stenting).



    • ACS or PCI: 180 mcg/kg IV bolus as soon as possible after diagnosis followed by infusion at 2 mcg/kg/min.

    • PCI: Add a second 180 mcg/kg bolus at 10 minutes.

    • In patients with creatinine clearance less than 50 mL/min, reduce the infusion to 1 mcg/kg/min.



    • 20 mg/10 mL (2 mg/mL) in a single-dose vial for bolus injection.

Send your message to this supplier
  • From:
  • To:
    Hainan Shuangcheng Pharmaceuticals Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service